On November 28, 2024, Canada’s Drug Agency (CDA) launched a consultation on its first-ever methods guide. The consultation ...

In the first study of its kind, research led by Canada's Centre for Addiction and Mental Health (CAMH) sheds light on the ...

Urges Congress Not to Give Up the Fight and to Act Swiftly to Advance Pharmacy Protections This YearWashington, DC, Dec. 18, ...

Here are our picks for the best instant approval credit cards in Canada. MoneySense is an award-winning magazine, helping Canadians navigate money matters since 1999. Our editorial team of trained ...

Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that as part of the acquisition of SRx Health Solutions Inc. (‘SRx Health’), a ...

Theralase®'s lead drug, Ruvidar TM (TLD-1433), activated by the TLC-3200 Medical Laser System ('TLC-3200') is currently under clinical investigation in Canada and the United States in a Phase II ...

Study II is a Phase 2, single arm, open label clinical study for patients diagnosed with BCG-Unresponsive NMIBC CIS designed in compliance with Health Canada and FDA guidance. The Study Procedure ...

is pleased to announce that it has launched a new Clinical Study Site ("CSS") for its bladder cancer clinical study; specifically, St. Joseph's Healthcare Hamilton (Hamilton, Ontario, Canada).

The Canadian economy grew at an annualized rate of one per cent in the third quarter, boosted by higher household and government spending, Statistics Canada said on Friday. The rate was in line ...